CDEK
← All organizations

Seneca Biopharma, Inc.

For profitWebsite ↗

Also known as: Suzhou Neuralstem Biopharmaceuticals

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Feb 1, 2011

Last known activity

Mar 1, 2016

Acquired by Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc → Seneca Biopharma, Inc. → Leading BioSciences, Inc on Apr 6, 2021

Timeline

1990s

  1. Jun 1, 1996

    Seneca Biopharma, Inc.— Founded

2020s

  1. Apr 6, 2021

    Leading BioSciences, Inc— Acquired By

  2. Apr 6, 2021

    Leading BioSciences, Inc— Now

  3. Apr 26, 2021

    Leading BioSciences, Inc— Acquired

Drugs by trial phase (6 distinct, 10 trials)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (0 own, 4 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (8)

Details

Founded
Rockville, MD, US Jun 1, 1996
Last known activity
Mar 1, 2016

Notes

Formerly Neuralstem Inc.